Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease
Chiara Rosso, Konstantin Kazankov, Ramy Younes, et al.
Journal of Hepatology (2019) Vol. 71, Iss. 5, pp. 1012-1021
Closed Access | Times Cited: 159

Showing 26-50 of 159 citing articles:

Tumor necrosis factor-α signaling in nonalcoholic steatohepatitis and targeted therapies
Sijia Lü, Yibing Wang, Junli Liu
Journal of genetics and genomics/Journal of Genetics and Genomics (2021) Vol. 49, Iss. 4, pp. 269-278
Open Access | Times Cited: 41
Impaired Hepatic Mitochondrial Capacity in Nonalcoholic Steatohepatitis Associated With Type 2 Diabetes
Sofiya Gancheva, S. Kahl, Dominik Pesta, et al.
Diabetes Care (2022) Vol. 45, Iss. 4, pp. 928-937
Open Access | Times Cited: 36
Dose-Response Associations of Metabolic Score for Insulin Resistance Index with Nonalcoholic Fatty Liver Disease among a Nonobese Chinese Population: Retrospective Evidence from a Population-Based Cohort Study
Xintian Cai, Jing Gao, Junli Hu, et al.
Disease Markers (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 29
Comparison of the diagnostic performance of twelve noninvasive scores of metabolic dysfunction-associated fatty liver disease
Haoxuan Zou, Xiaopu Ma, Fan Zhang, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 18
Lipidomic Analysis of Liver and Adipose Tissue in a High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice Model Reveals Alterations in Lipid Metabolism by Weight Loss and Aerobic Exercise
Thomai Mouskeftara, Olga Deda, Grigorios Papadopoulos, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1494-1494
Open Access | Times Cited: 6
The impact of short-term eucaloric low- and high-carbohydrate diets on liver triacylglycerol content in males with overweight and obesity: a randomized crossover study
Amalie London, Michael M. Richter, Kim A. Sjøberg, et al.
American Journal of Clinical Nutrition (2024) Vol. 120, Iss. 2, pp. 283-293
Open Access | Times Cited: 6
Metabolic diseases and interferon immune responses
Haiyan Zhou, Chunyan Liu, Yuerong Zhang, et al.
Deleted Journal (2025)
Open Access
The Gut Microbiota and Its Metabolites, Novel Targets for Treating and Preventing Non‐Alcoholic Fatty Liver Disease
Yinhua Ni, Liyang Ni, Fen Zhuge, et al.
Molecular Nutrition & Food Research (2020) Vol. 64, Iss. 17
Closed Access | Times Cited: 45
Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
Anika Nier, Yvonne Huber, Christian Labenz, et al.
Nutrients (2020) Vol. 12, Iss. 3, pp. 699-699
Open Access | Times Cited: 44
Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease
Ke Fan, Guohui Xue, Xueling Jiang, et al.
Cytokine (2020) Vol. 134, pp. 155184-155184
Closed Access | Times Cited: 44
Farnesoid X receptor (FXR) agonist ameliorates systemic insulin resistance, dysregulation of lipid metabolism, and alterations of various organs in a type 2 diabetic kidney animal model
Sang Youb Han, Hye Kyoung Song, Jin Joo, et al.
Acta Diabetologica (2021) Vol. 58, Iss. 4, pp. 495-503
Closed Access | Times Cited: 37
HIMF deletion ameliorates acute myocardial ischemic injury by promoting macrophage transformation to reparative subtype
Yanjiao Li, Min Dong, Qing Wang, et al.
Basic Research in Cardiology (2021) Vol. 116, Iss. 1
Open Access | Times Cited: 36
Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis
Rasmus Hvidbjerg Gantzel, Mikkel Breinholt Kjær, Tea Lund Laursen, et al.
Frontiers in Medicine (2021) Vol. 7
Open Access | Times Cited: 34
Disruption of adipocyte HIF-1α improves atherosclerosis through the inhibition of ceramide generation
Pengcheng Wang, Guangyi Zeng, Yu Yan, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 4, pp. 1899-1912
Open Access | Times Cited: 34
The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review
Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 33
Obesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction
Gabriele Mocciaro, Amalia Gastaldelli
Handbook of experimental pharmacology (2022), pp. 145-164
Closed Access | Times Cited: 22
Macrophage metabolism in nonalcoholic fatty liver disease
Wenhui Zhang, Ren Lang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Long-term and liver-selected ginsenoside C–K nanoparticles retard NAFLD progression by restoring lipid homeostasis
Chunyan Yue, Dandan Li, Shuxin Fan, et al.
Biomaterials (2023) Vol. 301, pp. 122291-122291
Closed Access | Times Cited: 12
An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillance
Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, et al.
Metabolism (2024), pp. 156080-156080
Open Access | Times Cited: 4
The Effects of Licoflavone on Hepatic Lipid Accumulation: In Vitro and In Vivo Studies
Fei Liu, Jiang Wang, Xin Tang, et al.
Food Bioscience (2025), pp. 106241-106241
Closed Access
Systemic aging and aging‐related diseases
Qiao Li, Nanyin Xiao, Heng Zhang, et al.
The FASEB Journal (2025) Vol. 39, Iss. 5
Open Access
Metabolic dysfunction and early‐onset colorectal cancer – how macrophages build the bridge
Katharina M. Scheurlen, Adrian T. Billeter, Stephen J. O’Brien, et al.
Cancer Medicine (2020) Vol. 9, Iss. 18, pp. 6679-6693
Open Access | Times Cited: 34
Molecular mechanisms of hepatic fibrosis in chronic liver diseases
Chiara Rosso, Gian Paolo Caviglia, Ramy Younes, et al.
Minerva Biotecnologica (2020) Vol. 32, Iss. 3
Closed Access | Times Cited: 33
Liver-targeting drugs and their effect on blood glucose and hepatic lipids
Amalia Gastaldelli, Norbert Stefan, Hans‐Ulrich Häring
Diabetologia (2021) Vol. 64, Iss. 7, pp. 1461-1479
Open Access | Times Cited: 29
Recent Update on the Molecular Mechanisms of Gonadal Steroids Action in Adipose Tissue
Agata Wawrzkiewicz–Jałowiecka, Anna Lalik, Graça Soveral
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5226-5226
Open Access | Times Cited: 27

Scroll to top